In these studies, ILC3s were shown to interact with tumor cells and tumor-associated fibroblasts via NKp44, and were associated with a protective role against cancer, whereas NKp30+ ILC2s interacted with tumors cells via B7H6 and promoted an immunosuppressive tumor microenvironment. Here, NCR3LG1 is linked to cancer.